News summary

Direct Pharmacological Activation of AMPK Modestly Extends Life in Short-Lived Species

Source: Fight Aging! • Published: 07 Oct 2026, 10:11

Summarized by Masters of Longevity from Fight Aging!.

Direct AMPK activation: a short, engaging article previewing research that tests a compound’s lifespan effects across yeast, worms, flies, and mice.

Direct Pharmacological Activation of AMPK Modestly Extends Life in Short-Lived Species
Key Takeaways
  • The direct AMPK activator compound 991 extended lifespan in Drosophila melanogaster, Caenorhabditis elegans, and Schizosaccharomyces pombe.
  • In mice, 991 treatment produced a pro-longevity proteomic signature but did not report large lifespan gains.
Read the full article at Fight Aging! ↗

Continue exploring

Recommended MoL Picks

MoL PickSemaglutide Extended Lifespan in Mice. What Would Make It a Human Longevity Drug?A new animal study sharpens an important question: when do benefits in a particular disease become evidence for a longer, healthier life?MoL PickGrowth Hormone Receptor Deletion Extends Mouse LifespanStudy summary: researchers switched off the growth hormone receptor in middle-aged mice and followed survival and physical function.MoL PickPlan Your Health Tests in Three MinutesThe free Personal Health Diagnostics Planner turns a short questionnaire into a ranked, personalised PDF: a clearer starting point for deciding which health checks deserve attention now.